The Ridgewood Blog Brings a Free Market Laissez-faire Point of View to Local, New Jersey State and National Issues.
CDC Recommends all Pregnant Women Receive the COVID Vaccine
the staff of the Ridgewood blog
Ridgewood NJ, according to Johns Hopkins Center for Health Security, following the publication of preliminaryfindings detailing the effectiveness of SARS-CoV-2 mRNA vaccines in pregnant women in the April 21 New England Journal of Medicine, US CDC Director Dr. Rochelle Walensky said during a briefing on April 23 that the agency recommends all pregnant women receive a vaccine. Dr. Walensky noted that no safety concerns arose for pregnant women vaccinated during their third trimester nor for their infants, although the study did not include the J&J-Janssen vaccine. Experts have taken special interest in the effect of vaccinations in pregnant persons, and a study published on April 22 in JAMA Pediatrics shows they are at ahigher risk for complications due to COVID-19. The research, which described the experiences of 2,130 pregnant persons in 18 countries, concluded that the risks of COVID-19-related morbidity and mortality among pregnant people and their infants are greater than previously thought, underscoring the importance of vaccination for pregnant women.
The New England Journal of Medicine on April 21 published a study of preliminary findings of mRNA SARS-CoV-2 vaccine safety among pregnant people. Researchers from the CDC’s V-safe COVID-19 Pregnancy Registry Team used data from the agency’s V-safe surveillance system, the V-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS). A total of 35,691 V-safe participants aged 16 to 54 years identified as pregnant. Among those people, injection site pain was reported more frequently than among the nonpregnant population, but headache, muscle aches, chills, and fever were reported less frequently. Of 221 pregnancy-related adverse events reported to the VAERS, the most frequently reported was spontaneous abortion (46 cases). The researchers note that although not directly comparable, the proportions of adverse pregnancy and neonatal outcomes (eg, fetal loss, preterm birth, small size for gestational age, congenital anomalies, and neonatal death) among vaccinated persons who had completed pregnancy were similar to incidences reported in studies of pregnant people conducted prior to the COVID-19 pandemic. The preliminary findings did not show obvious safety signals for pregnant persons receiving mRNA SARS-CoV-2 vaccines, but the researchers noted the need for continued monitoring. The American Society for Reproductive Medicine has encouraged everyone, including pregnant persons and those seeking to become pregnant, to receive a SARS-CoV-2 vaccination.